Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1993-8-31
pubmed:abstractText
Orthotopic liver transplantation has become the accepted treatment for end-stage liver disease in children. To evaluate the efficacy of the University of Wisconsin (UW) preservation solution in pediatric liver transplantation, a group of 34 livers preserved with UW solution was compared in a nonrandomized fashion with a historical control group of 34 livers preserved with Euro Collins (EC) solution. Primary graft nonfunction did not occur in either group. Both groups were similar with respect to age, sex, weight, diagnosis, severity of the recipient's condition, donor condition at harvest, donor/recipient blood type match, and immunosuppressive management. The UW group had a significantly higher bilirubin, AST, ALT, and GGT during the first week after transplantation when compared with the EC group but no significant differences were noted after the ninth post-transplant day. No differences were noted when the groups were compared as to surgery time (9.1 v 8.4 hours), blood volumes replaced (1.8 v 2.0), number of ICU days (5.0 v 6.5), total number of infections per graft (1.0 v 0.8), total hospital days (31 v 30), and hospital cost ($134,000 v $126,000). The total preservation time was improved from 7 hours (range, 3.2 to 9.9) in the EC group to 13.9 hours (range, 6.9 to 22.3) in the UW group (P < .001). UW solution allows a significant increase in cold ischemic time in liver transplantation when compared with EC. This increase in preservation time resulted in no detrimental effect when compared with EC and potentially led to milder episodes of rejection in the postoperative period.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-3468
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
707-11
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8340864-Adenosine, pubmed-meshheading:8340864-Adolescent, pubmed-meshheading:8340864-Allopurinol, pubmed-meshheading:8340864-Child, pubmed-meshheading:8340864-Child, Preschool, pubmed-meshheading:8340864-Female, pubmed-meshheading:8340864-Glutathione, pubmed-meshheading:8340864-Graft Rejection, pubmed-meshheading:8340864-Humans, pubmed-meshheading:8340864-Hypertonic Solutions, pubmed-meshheading:8340864-Infant, pubmed-meshheading:8340864-Infection, pubmed-meshheading:8340864-Insulin, pubmed-meshheading:8340864-Liver, pubmed-meshheading:8340864-Liver Transplantation, pubmed-meshheading:8340864-Male, pubmed-meshheading:8340864-Organ Preservation, pubmed-meshheading:8340864-Organ Preservation Solutions, pubmed-meshheading:8340864-Postoperative Complications, pubmed-meshheading:8340864-Raffinose
pubmed:year
1993
pubmed:articleTitle
University of Wisconsin preservation solution compared with Euro Collins preservation solution in pediatric liver transplantation.
pubmed:affiliation
Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75235-8580.
pubmed:publicationType
Journal Article, Comparative Study